monosialic gangliosides

DRUG2 trials

Sponsors

Henan Cancer Hospital

Conditions

Early Breast Cancer

Phase 2

A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity

CompletedNCT04222790

Henan Cancer HospitalEarly Breast Cancer

Start: 2020-08-28End: 2022-04-21Updated: 2023-12-04

GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel

WithdrawnNCT04538833

Henan Cancer HospitalEarly Breast Cancer

Start: 2020-09-09End: 2022-08-22Updated: 2022-11-23

Related Papers

Abstract PO3-28-04: Ganglioside-Monosialic Acid for Prevention of Peripheral Neuropathy Induced by nab-Paclitaxel in Breast Cancer Patients (HELEN-004): A Randomized, Double-Blind, Phase II Trial

Cancer Research2024-05-02